Sunil Patel's most recent trade in Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B was a trade of 4,340 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ligand Pharma Inc (Class B) | Sunil Patel | Former Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Nov 2022 | 4,340 | 0 | - | - | Employee Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Sunil Patel | Former Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Nov 2022 | 1,004 | 28,820 (0%) | 0% | - | Common Stock | |
| Ligand Pharma Inc (Class B) | Sunil Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 4,340 | 4,340 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Sunil Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 1,004 | 29,824 (0%) | 0% | 0 | Common Stock | |
| Ligand Pharma Inc (Class B) | Sunil Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 3,269 | 3,269 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Sunil Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 630 | 28,820 (0%) | 0% | 0 | Common Stock |